Related Experiment Video
Updated: Jan 23, 2026

Generation of Monoclonal Antibodies Against Natural Products
Published on: April 6, 2019
In vitro and in vivo effector function of rat IgG2a monoclonal anti-S. mansoni antibodies
Rat IgG2a monoclonal antibodies have been produced after fusion of spleen cells from LOU/C rats infected with S. mansoni for 5 wk and IR983F nonsecreting rat myeloma cells. The cell supernatants of one particular IgG2a-producing clone (IPL Sm1) as well as ascitic fluids induced by this clone revealed anti-S. mansoni activity detected by immunofluorescence on schistosoma sections. In vitro studies of the effector function of such antibodies revealed that the rat IgG2a monoclonal antibodies mediated high levels of rat eosinophil-dependent cytotoxic effect against S. mansoni schistosomula, similar to that obtained with 5-week infected rat serum. Passive transfer experiments carried out with IPL Sm1 ascitic fluid showed a significant level of passive protection against a challenge infection. These results indicate a possible use of the monoclonal antibodies in analyzing in vivo functions of IgG2a antibodies, as well as in isolating potentially protective target antigens.
Rat IgG2a monoclonal antibodies have been produced after fusion of spleen cells from LOU/C rats infected with S. mansoni for 5 wk and IR983F nonsecreting rat myeloma cells. The cell supernatants of one particular IgG2a-producing clone (IPL Sm1) as well as ascitic fluids induced by this clone revealed anti-S. mansoni activity detected by immunofluorescence on schistosoma sections. In vitro studies of the effector function of such antibodies revealed that the rat IgG2a monoclonal antibodies mediated high levels of rat eosinophil-dependent cytotoxic effect against S. mansoni schistosomula, similar to that obtained with 5-week infected rat serum. Passive transfer experiments carried out with IPL Sm1 ascitic fluid showed a significant level of passive protection against a challenge infection. These results indicate a possible use of the monoclonal antibodies in analyzing in vivo functions of IgG2a antibodies, as well as in isolating potentially protective target antigens.
More Related Videos
04:47A Method to Assess Fc-mediated Effector Functions Induced by Influenza Hemagglutinin Specific Antibodies
Published on: February 23, 2018
16:07Determination of the Relative Potency of an Anti-TNF Monoclonal Antibody mAb by Neutralizing TNF Using an In Vitro Bioanalytical Method
Published on: September 16, 2017
Related Concept Videos
Equivalence: In Vitro and In Vivo Bioequivalence
Drug Product Performance: In Vitro–In Vivo Correlation
Antibody Structure
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
Antibody Actions
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
Waterproofing and Anti-Bacterial Admixtures in Concrete
Waterproofing admixtures render concrete hydrophobic,...
Antibody Structure and Classes
The basic structure of an antibody consists of four protein chains: two identical heavy chains and two identical light chains. These chains are held together by disulfide bonds and other non-covalent interactions, forming a Y-shaped structure.